In the randomized study by Champlin, the 5-year overall probabilities of survival after alloHCT from MSD were 74% after cyclophosphamide alone and 80% after cyclophosphamide and equine ATG, but the difference did not reach statistical significance [ 35 ].
← all excerpts
Fludarabine-Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia.
1
—
—